BRCA1/2 mutation carriers can have up to a six-fold higher lifetime risk of developing breast cancer [4,5,6], and approximately a four-fold increased risk of developing a second primary contralateral breast cancer compared to women without this mutation [7]. This evidence concerns the gene BRCA1 and breast carcinoma.